| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mereo Biopharma Group Plc (MREO) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 4 sells. MREO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Hughes-Wilson Alexandra65 | See Remarks | Sell | 33,102 | $3.49 | $115,369.00 | -26.4% | +16.0% | -19.8% | |
| May 22, 2024 | Hughes-Wilson Alexandra65 | See Remarks | Sale+OE | 100,432 | $2.97 | $297,787.58 | -52.4% | +48.5% | -23.7% |